Top Brain Cancer Treatment Doctors in Israel

Dr. Zvi Harry Rappaport is a specialized Neurosurgeon in Israel. And one of the most sought after medical specialists in Tel Aviv, Israel. The doctor has over 38 Years of experience and is associated with Assuta Hospital.

Qualifications :

• 1967 - 1969 , Philosophy-Physics, Columbia University, New York, USA
• 1969, BA degree
• 1969 - 1973, Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• 1973, MD degree

Hospital Address :

Assuta Hospital, HaBarzel Street, Tel Aviv-Yafo, Israel

What is the medical expertise of Dr Zvi Harry Rappaport?

• With 38 years of experience, Dr Zvi Harry Rappaport is a respected neurosurgeon specializing in Epilepsy surgery, acoustic neuroma surgery, deep brain stimulation for movement disorders, and image-guided neurosurgery.
• He completed Fellowship in Surgery at Columbia University, Presbyterian Medical Center, New York, USA and Fellowship in Physiological Neurosurgery at Westchester Co.Medical Center, Valhalla, NY, USA (IS Cooper). Dr Rappaport also finished the Acoustic neuroma surgery practical course at the Congress of Neurological Surgery, Washington, DC, U.S.A.
• Dr Rappaport is a Diplomat of the National Board of Medical Examiners, USA. He has a specialist certification from the American Board of Neurological Surgery.
• Dr Rappaport holds professional memberships in organizations such as the Israel Neurosurgical Association, the European Association of Neurosurgeons, the International Society for the Study of Pain and the World Federation of Neurosurgical Societies.
• Over the course of his career, he has published 100+ peer-reviewed scientific articles in journals of repute. These are:
  1. Neuberger A, Shofty B, Bishop B, Naffaa ME, Binawi T, Babich T, Rappaport ZH, Zaaroor M, Sviri G, Yahav D, Paul M. Risk factors associated with death or neurological deterioration among patients with Gram-negative post neurosurgical meningitis. Clin Microbiol Infect. 2016 Jun;22(6):573.e1-4.
  2. Laviv Y, Jackson S, Rappaport ZH. Persistent communicating hydrocephalus in adult tuberous sclerosis patients: a possible therapeutic role for everolimus. Acta Neurochir (Wien). 2015 Feb;157(2):241-5.
  3. Shofty B, Neuberger A, Naffaa ME, Binawi T, Babitch T, Rappaport ZH, Zaaroor M, Sviri G, Paul M. Intrathecal or intraventricular therapy for post-neurosurgical Gram-negative meningitis: matched cohort study. Clin Microbiol Infect. 2016 Jan;22(1):66-70.